Market Overview

Deutsche Bank Reiterates Buy Rating On CVD And ICLR


Deutsche Bank is reiterating its Buy rating on shares of Covance Inc. (NYSE: CVD) and ICON plc (NASDAQ: ICLR).

“Key takeaways from the Annual Partnerships in Clinical Trials Conference: 1) Vendor consolidation amongst biopharma clients (from 10-to-15 to 2-to-4) and momentum towards strategic deals continues to accelerate,” Deutsche Bank writes.

“2) Emerging markets and increased penetration of R&D to drive industry growth. 3) Impact on OMs from pricing discounts to be largely offset by efficiency gains. Given our thesis, we reiterate our Buy rating of CVD (best leverage to strategic deals) and ICLR (GARP).”

ICON closed Monday at $21.48; Covance closed at $57.46.

Posted-In: covance Deutsche Bank ICONAnalyst Ratings


Related Articles (ICLR + CVD)

View Comments and Join the Discussion!

Latest Ratings

RPAYCantor FitzgeraldMaintains18.0
CMSCredit SuisseDowngrades
PBCTStephens & Co.Maintains15.5
TTECCowen & Co.Initiates Coverage On50.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at